Emergent BioSolutions Inc. (EBS)

NYSE: EBS · Real-Time Price · USD

4.830

-0.340 (-6.58%)

At close: Apr 3, 2025, 4:00 PM

4.910

+0.080 (1.66%)

After-hours: Apr 3, 2025, 8:00 PM EDT

Emergent BioSolutions Market Cap

Emergent BioSolutions has a market cap or net worth of $262.45 million as of April 3, 2025. Its market cap has increased by 103.61% in one year.

Market Cap

262.45M

Enterprise Value

844.75M

1-Year Change

103.61%

Ranking

#3349

Market Cap Chart

Since November 15, 2006, Emergent BioSolutions's market cap has decreased from $320.80M to $262.45M, a decrease of -18.19%. That is a compound annual growth rate of -1.09%.

Market Cap History

Date	Market Cap	% Change
Apr 2, 2025	280.90M	-45.77%
Dec 31, 2024	518.00M	316.06%
Dec 29, 2023	124.50M	-78.87%
Dec 30, 2022	589.20M	-74.81%
Dec 31, 2021	2.34B	-50.75%
Dec 31, 2020	4.75B	70.50%
Dec 31, 2019	2.79B	-7.78%
Dec 31, 2018	3.02B	57.00%
Dec 29, 2017	1.92B	44.63%
Dec 30, 2016	1.33B	-14.64%
Dec 31, 2015	1.56B	52.38%
Dec 31, 2014	1.02B	22.29%
Dec 31, 2013	836.10M	45.38%
Dec 31, 2012	575.10M	-5.00%
Dec 30, 2011	605.40M	-25.67%
Dec 31, 2010	814.50M	94.58%
Dec 31, 2009	418.60M	-46.42%
Dec 31, 2008	781.20M	419.07%
Dec 31, 2007	150.50M	-50.82%
Dec 29, 2006	306.00M	-4.61%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	732.64B
UnitedHealth Group	480.27B
Johnson & Johnson	378.44B
AbbVie	371.74B
Novo Nordisk	302.16B
Abbott Laboratories	228.60B
AstraZeneca	225.46B
Merck & Co.	223.21B

Market Cap Rankings